BOT 5.07% 32.8¢ botanix pharmaceuticals ltd

Hello jcurveReport from 2017 page 13 indicates the following; I...

  1. 2,655 Posts.
    lightbulb Created with Sketch. 160
    Hello jcurve

    Report from 2017 page 13 indicates the following; I assume the Patent is still current?

    https://botanixpharma.com/wp-content/uploads/2020/06/170322-BOT-Initiation-Report.pdf


    The patent for Permetrex is held by Dr Eugene Cooper, who in turn has granted BOT a license for exclusive worldwide use of the drug delivery technology when used with any drug active purposed for the topical treatment of any skin disease. It is the responsibility of Dr Cooper to enforce and defend his intellectual property rights with respect to Permetrex. Any failure to do so, on Dr Cooper’s behalf, may present a significant risk to BOT and its wider portfolio of pipeline products.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
32.8¢
Change
-0.018(5.07%)
Mkt cap ! $597.3M
Open High Low Value Volume
34.0¢ 34.0¢ 32.8¢ $1.370M 4.106M

Buyers (Bids)

No. Vol. Price($)
27 713595 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 530741 11
View Market Depth
Last trade - 13.53pm 05/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.